Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
ESMO Open
|
September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis
M Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2014
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group
M Toulmonde, S Bonvalot, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2014
Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group
M Toulmonde, S Bonvalot, P Méeus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
ESMO Open
|
February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
C Moreau-Bachelard, L Campion, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial
A Le Cesne, J-Y Blay, D Cupissol, et al.
ESMO Open
|
June 17, 2021
European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN
J-Y Blay, P Casali, C Bouvier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2023
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial
B Audinot, D Drubay, N Gaspar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L Khoja, E G Atenafu, S Suciu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patients
J-Y Blay, P Soibinet, N Penel, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
ESMO Open
|
September 18, 2022
Association between recent pregnancy or hormonal contraceptive exposure and outcome of desmoid-type fibromatosis
M Debaudringhien, J-Y Blay, A-M Bimbai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2014
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group
M Toulmonde, S Bonvalot, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2014
Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group
M Toulmonde, S Bonvalot, P Méeus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2012
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
P Pautier, A Floquet, L Gladieff, et al.
ESMO Open
|
February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
C Moreau-Bachelard, L Campion, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2021
A randomized phase III trial comparing trabectedin to best supportive care in patients with pre-treated soft tissue sarcoma: T-SAR, a French Sarcoma Group trial
A Le Cesne, J-Y Blay, D Cupissol, et al.
ESMO Open
|
June 17, 2021
European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN
J-Y Blay, P Casali, C Bouvier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2023
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial
B Audinot, D Drubay, N Gaspar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2019
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study
L Khoja, E G Atenafu, S Suciu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patients
J-Y Blay, P Soibinet, N Penel, et al.
Page
of 8